2014年
- Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Hirata H, Sugimachi K, Takahashi Y, Ueda M, Sakimura S, Uchi R, Kurashige J, Takano Y, Nanbara S, Komatsu H, Saito T, Shinden Y, Iguchi T, Eguchi H, Atsumi K, Sakamoto K, Doi T, Hirakawa M, Honda H, Mimori K.
Ann Surg Oncol. 2014 Nov 18. [Epub ahead of print] - Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition.
Hamabe A, Konno M, Tanuma N, Shima H, Tsunekuni K, Kawamoto K, Nishida N, Koseki J, Mimori K, Gotoh N, Yamamoto H, Doki Y, Mori M, Ishii H.
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15526-31. doi: 10.1073/pnas.1407717111. Epub 2014 Oct 13. - MACC1 expression levels as a novel prognostic marker for colorectal cancer.
Yamamoto H, Miyoshi N, Mimori K, Hitora T, Tokuoka M, Fujino S, Ellis HL, Ishii H, Noura S, Ohue M, Yano M, Doki Y, Mori M.
Oncol Lett. 2014 Nov;8(5):2305-2309. Epub 2014 Aug 19. - ANXA9 gene expression in colorectal cancer: A novel marker for prognosis.
Miyoshi N, Yamamoto H, Mimori K, Yamashita S, Miyazaki S, Nakagawa S, Ishii H, Noura S, Ohue M, Yano M, Doki Y, Mori M.
Oncol Lett. 2014 Nov;8(5):2313-2317. Epub 2014 Aug 25. - Prognostic significance of high mobility group box 1 (HMGB1) expression in patients with colorectal cancer.
Ueda M, Takahashi Y, Shinden Y, Sakimura S, Hirata H, Uchi R, Takano Y, Kurashige J, Iguchi T, Eguchi H, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.
Anticancer Res. 2014 Oct;34(10):5357-62. - Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells.
Kondo Y, Iwao T, Yoshihashi S, Mimori K, Ogihara R, Nagata K, Kurose K, Saito M, Niwa T, Suzuki T, Miyata N, Ohmori S, Nakamura K, Matsunaga T.
PLoS One. 2014 Aug 1;9(8):e104010. doi: 10.1371/journal.pone.0104010. eCollection 2014. - Clinical significance of GAB2, a scaffolding/docking protein acting downstream of EGFR in human colorectal cancer.
Matsumura T, Sugimachi K, Takahashi Y, Uchi R, Sawada G, Ueda M, Hirata H, Sakimura S, Ueo H, Takano Y, Kurashige J, Shinden Y, Eguchi H, Sudo T, Yamamoto H, Doki Y, Mori M, Mimori K.
Ann Surg Oncol. 2014 Dec;21 Suppl 4:S743-9. doi: 10.1245/s10434-014-3889-x. Epub 2014 Jul 17. - A single nucleotide polymorphism in fibronectin?1 determines tumor shape in colorectal cancer.
Kida H, Takano Y, Yamamoto K, Mori M, Yanaga K, Tanaka J, Kudo SE, Mimori K.
Oncol Rep. 2014 Aug;32(2):548-52. doi: 10.3892/or.2014.3251. Epub 2014 Jun 12. - Human colorectal CD24+ cancer stem cells are susceptible to epithelial-mesenchymal transition.
Okano M, Konno M, Kano Y, Kim H, Kawamoto K, Ohkuma M, Haraguchi N, Yokobori T, Mimori K, Yamamoto H, Sekimoto M, Doki Y, Mori M, Ishii H.
Int J Oncol. 2014 Aug;45(2):575-80. doi: 10.3892/ijo.2014.2462. Epub 2014 May 23. - Loss of CDCP1 Expression Promotes Invasiveness and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Sawada G, Takahashi Y, Niida A, Shimamura T, Kurashige J, Matsumura T, Ueo H, Uchi R, Takano Y, Ueda M, Hirata H, Sakimura S, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Miyano S, Doki Y, Mori M, Mimori K.
Ann Surg Oncol. 2014 May 22. [Epub ahead of print] - A case of gastric plexiform fibromyxoma: radiological and pathological findings.
Sakamoto K, Hirakawa M, Atsumi K, Mimori K, Shibata K, Tobo T, Yamamoto H, Honda H.
Jpn J Radiol. 2014 Apr 18. [Epub ahead of print] - Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma.
Kita Y, Nishizono Y, Okumura H, Uchikado Y, Sasaki K, Matsumoto M, Setoyama T, Tanoue K, Omoto I, Mori S, Owaki T, Ishigami S, Nakagawa H, Tanaka F, Mimori K, Mori M, Natsugoe S.
Oncol Rep. 2014 May;31(5):1986-92. doi: 10.3892/or.2014.3062. Epub 2014 Mar 5. - Decreased miR-340 expression in bone marrow is associated with liver metastasis of colorectal cancer.
Takeyama H, Yamamoto H, Yamashita S, Wu X, Takahashi H, Nishimura J, Haraguchi N, Miyake Y, Suzuki R, Murata K, Ohue M, Kato T, Takemasa I, Mizushima T, Ishii H, Mimori K, Doki Y, Mori M.
Mol Cancer Ther. 2014 Apr;13(4):976-85. doi: 10.1158/1535-7163.MCT-13-0571. Epub 2014 Jan 21. - Allelic Imbalance at an 8q24 Oncogenic SNP is Involved in Activating MYC in Human Colorectal Cancer.
Sugimachi K, Niida A, Yamamoto K, Shimamura T, Imoto S, Iinuma H, Shinden Y, Eguchi H, Sudo T, Watanabe M, Tanaka J, Kudo S, Hase K, Kusunoki M, Yamada K, Shimada Y, Sugihara K, Maehara Y, Miyano S, Mori M, Mimori K.
Ann Surg Oncol. 2014 Jan 6. [Epub ahead of print] - Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.
Takahashi Y, Iwaya T, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.
Ann Surg Oncol. 2014 Jan;21(1):205-12. doi: 10.1245/s10434-013-3264-3. Epub 2013 Sep 18.